1Ackerman L V. Verrucous carcinoma of the oral cavity[J]. Surgery, 1948,23(4) :670-678.
2La Vecchia C, Lucehini F, Negri E, et al. Trends in oral cancer mortality in Europe[J]. Oral Oncol,2004,40(4) :433-439.
3Patel K R,Chernock R D,Zhang T R,et al. Verrucous carcino- mas of the head and neck, including those with associated squamous cell carcinoma,lack transcriptionally active high-risk human papillomavirus[J]. Hum Pathol, 2013,44 ( 11 ): 2385- 2392.
4Shenoi R,Devrukhkar V, Sharma B K, et al. Demographic and clinical profile of oral squamous cell carcinoma patients:A ret- rospective study[J]. Indian J Cancer,2012,49(1) :21-26.
5Lubin J H,Cook M B,Pandeya N,et al. The importance of ex- posure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocareinoma and squamous cell carcinoma in the Barrett's Esophagus and Esophageal Adeno- carcinoma Consortium [ J ]. Cancer Epidemiol, 2012, 36 ( 3 ) : 306-316.
6HaP K,Pai S I,Westra W H,et al. Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity[J]. Clini Cancer Res, 2002,8(5) .. 1203-1209.
7Poling J S,Ma X J,Bui S,et al. Human papillomavirus (HPV) sta- tus of non-tobacco related squamous cell carcinomas of the lateral tongue[J].Oral Oneol, 2014,50(4) :306-310.
8Kang C J,Chang J T C,Chen T M,et al. Surgical treatment of oral Verrucous carcinoma[J]. Choice, 2003,1 : 2.
9Walvekar R R,Chaukar D A,Deshpande M S,et al. Verrucous carcinoma of the oral cavity:a clinical and pathological study of 101 cases[J]. Oral Oncol,2009,45(1) :47-51.
2Potgens AJG,Westphal GR,Dewaal RMW,et al. The role of vascular permeability factor and fibroblast growth factor in tumor[J]. Angiogenesis Bio Chem Hoppe-- seyler, 1995,376( 1 ) : 57-- 60.
3Matsumoto Y, Ishiko O, Nishimura S, et al. Angiogenesis in metastatic verrucous carcinoma of the uterine cervix[J]. Oncol Rep, 2000,7(5) : 1079-1082.
4Fujiwaki R, Hata K, Iida K, et al. Vascular endothelial growth factor expression in progression of cervical cancer: correlation with thymidine phosphorylase expression, angiogenesis, tumor cell proliferation, and apoptosis [ J ]. Anticancer Res, 2000, 20 ( 2B ) : 1317-1322.
5O- charoenrat P, Rhys -- Evans P, Eccles SA. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis[J]. Cancer,2001,92(3) :556-568 .
6Hata K, Fujiwaki R, Nakayama K, et al. Expression of thymidine phosphorylase and vascular endothelial growth factor in epithelial ovarian cancer: correlation with angiogenesis and progression of the tumor[J]. Anticancer Res, 2000,20(5C) :3941 --3949.
7Vidal S, Oliveira MC, Kovacs K, et al. Immunolocalization of vascular endothelial growth factor in the GH3 cell line[J]. Cell Tissue Res,2000,300(1) :83-88.
8Fehrenbach H, Kasper M,Haase M, et al. Differential immunolocalization of VEGF in rat and human adult lung,and inexperimental rat lung fibrosis: light, fluorescence, and electron microscopy[J]. Anat Rec. 1999.254(1 ) .ill --73.
9Shibuya M. Role of VEGF-- Flt receptor system in nomal and tumor angiogenesis[ J ]. Advanced Cancer Research, 1995,67: 281 - 316.
10Ferrara N, Davis - smith T. The biology of vascular endothelial growth factor[J]. Endocr Rev, 1997,18:4-25.
